Brief: Dermapharm Holding: Q1 Consolidated Revenue Up 9.1% At EUR 231.6 Mln
May 18 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* Q1 CONSOLIDATED REVENUE UP 9.1% TO EUR 231.6 MILLION
* Q1 ADJUSTED CONSOLIDATED EBITDA RISES 17.9% TO EUR 75.1
MILLION
* BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR 2022 OVERALL:
CONSOLIDATED REVENUE EXPECTED TO INCREASE BY 10-13%, EBITDA BY
3-7%
Source text for Eikon: ID:nEQ5gfFL1a
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit